Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

IHE vs. IXJ: which is better?

Bottom line

IHE vs IXJ: the short answer

IHE (iShares U.S. Pharmaceuticals ETF) and IXJ (iShares Global Healthcare ETF) are quite different portfolios: only about 35% of their top holdings (by weight) are shared.

But IXJ is far broader, holding 124 positions to 59 for IHE, so beyond the top names it adds exposure IHE doesn't have.

IHE is cheaper at 0.37% vs 0.38% — a difference of $1.00 a year per $10,000 invested.

Over five years, IHE returned +9.1% a year vs +6.4% for IXJ.

Updated Nov 19, 2026

IHE vs IXJ side by side

IHEIXJ
TypeETFETF
Fund familyiSharesiShares
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.37%0.38%
Annual cost per $10k$37$38
10-yr cost on $10k (prospectus)$468$480
Max front loadNoneNone
12b-1 fee0%0%
1-yr return+31.7%+14.9%
5-yr return (annualized)+9.1%+6.4%
10-yr return (annualized)+6.2%+8.2%
Best quarter+17.6%+13.6%
Worst quarter−16.0%−11.8%
Net assets (fund)$1.1B$3.8B
Number of holdings59124
Portfolio turnover29%2%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearIHEIXJDifference
2025+31.7%+14.9%+16.9%
2024+8.1%+0.6%+7.5%
2023+1.0%+3.5%−2.5%
2022−4.8%−4.7%−0.1%
2021+12.8%+19.5%−6.7%
2020+13.8%+12.5%+1.3%
2019+15.5%+23.4%−7.9%
2018−7.7%+2.9%−10.5%
2017+10.7%+20.3%−9.7%
2016−11.7%−6.2%−5.5%

Source: Fund prospectus bar charts

Holdings overlap

5 of IHE's top 25 holdings also appear in IXJ's top 25.

Shared top holdings
HoldingIHEIXJ
Johnson & Johnson22.44%7.04%
Eli Lilly And Company22.25%10.93%
Merck & Co., Inc.4.55%4.12%
Bristol-myers Squibb Company4.37%1.53%
Pfizer Inc.3.96%1.78%

Source: SEC Form N-PORT

IHE top 10

  1. Johnson & Johnson — 22.44%
  2. Eli Lilly And Company — 22.25%
  3. BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 6.24%
  4. Merck & Co., Inc. — 4.55%
  5. Bristol-myers Squibb Company — 4.37%
  6. Royalty Pharma Plc — 4.34%
  7. Viatris Inc. — 4.22%
  8. Pfizer Inc. — 3.96%
  9. Zoetis Inc. — 3.73%
  10. Jazz Pharmaceuticals Public Limited Company — 3.45%

IXJ top 10

  1. Eli Lilly And Company — 10.93%
  2. Johnson & Johnson — 7.04%
  3. Abbvie Inc. — 5.12%
  4. Unitedhealth Group Incorporated — 4.40%
  5. Merck & Co., Inc. — 4.12%
  6. Astrazeneca Plc — 3.76%
  7. Roche Holding AG — 3.75%
  8. Novartis AG — 3.71%
  9. Amgen Inc. — 2.54%
  10. Thermo Fisher Scientific Incorporated — 2.42%

FAQ

What is the difference between IHE and IXJ?
IHE (iShares U.S. Pharmaceuticals ETF) and IXJ (iShares Global Healthcare ETF) are quite different portfolios: only about 35% of their top holdings (by weight) are shared. But IXJ is far broader, holding 124 positions to 59 for IHE, so beyond the top names it adds exposure IHE doesn't have.
Which is cheaper, IHE or IXJ?
IHE has the lower expense ratio (0.37%).
Should I own both IHE and IXJ?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.